SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-310054
Filing Date
2022-12-21
Accepted
2022-12-21 16:06:22
Documents
13
Period of Report
2022-12-15
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d440213d8k.htm   iXBRL 8-K 29345
2 EX-3.1 d440213dex31.htm EX-3.1 240431
  Complete submission text file 0001193125-22-310054.txt   438342

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bmrn-20221215.xsd EX-101.SCH 2842
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmrn-20221215_lab.xml EX-101.LAB 17981
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmrn-20221215_pre.xml EX-101.PRE 11253
7 EXTRACTED XBRL INSTANCE DOCUMENT d440213d8k_htm.xml XML 3479
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26727 | Film No.: 221478528
SIC: 2834 Pharmaceutical Preparations